| Micro-channel |
 |
|
|
|
|
|
| |
| Fosun action, the company's medical equipment company will be listed on September 19! |
| |
| Author：中國銘鉉 企劃部 Release Time：2017-9-18 11:26:15 Number Browse：1122 |
| |
Medical network - September 18 league just 3.3 billion news out of financing, fosun medicine, medical apparatus and instruments subsidiary plans to the day after tomorrow (19 September) is listed on the Hong Kong main board, medical apparatus and instruments circle of capital operation is accelerating.
Four years ago
Sisram Medical Ltd (SisramMed), a subsidiary of fosun pharmaceutical, is planning to list in Hong Kong the day after tomorrow and will become the first Israeli company to list in Hong Kong.
The Sisram meds, was established in April 2013 in Israel's Alma Lasers power source which is a leading global medical beauty equipment suppliers, with independent design, development and production capacity, and often the company's own innovation and patent technology.
According to the medical insight report, Sisram Med is the largest supplier of energy source medical cosmetology devices in China, and the world's fifth largest market share.
Sisram Med brand? Alma? We have developed, produced and sold more than 50 different types of medical beauty instruments and more than 100 applications for surgery, medical beauty and beauty plates.
Go public in Hong Kong
The Hong Kong capital market is one of the most important financial centers in the asia-pacific region. "Internationalization" is one of the important labels of the Hong Kong stock market.
Israel now world-famous with high and new technology industry, in military science and technology, electronics, communication, computer software, and medical equipment, biological engineering technology, agriculture, aviation and other fields with advanced technical level.
Israel, as the "nation of innovation", is the cradle of entrepreneurs. For israelis, innovation and entrepreneurship have long been part of everyday life.
At present, the quality of Israel startup has landed in London, New York and other major capital markets, the number of Israeli company nasdaq trading alone more than 80, the world in the third after the United States and Canada.
Similarly, on the London stock exchange, Israel has become the largest listed company in London, with the exception of local companies.
Due to the nature of the high-tech content brought huge growth space, Israeli start-up to become the star of the capital market, but these high-tech start-ups has landed in Hong Kong.
Sisram Med is Israel's first landing Hong Kong enterprises, as a registered in Israel, big shareholders and domestic fosun medicine, domestic will undoubtedly become one of the important market. Therefore, the choice of Hong Kong listing is undoubtedly very desirable.
Laser beauty market
According to the Medical Insight report, the Medical cosmetic treatment of the global total consumer spending in 2016 was $25.9 billion, and expected growth in 2021 to $34.1 billion, an annual compound growth rate of 5.7%, analysis, the main driving factors are the following:
Discretionary income around the world are rising steadily, attention and acceptance of cosmetic treatment, more people want to get or keep a younger appearance, a longer life expectancy and aging population promote the growth of anti-aging treatment, as well as people's needs are constantly to noninvasive and minimally invasive medical hairdressing.
And trend of China's growth is more significant, Medical Insight report expected sales revenue resulting from the laser cosmetic instrument will be increased from $2016 in 159 million to $2021 in 327 million, the annual compound growth rate of 15.5%. Sisram Med will undoubtedly benefit as the largest supplier of laser medical beauty equipment in the Chinese market.
It is understood that Sisram since its establishment has sold more than 27300 mainframe treatment system, and the application end, more than 117600 in North America, Europe, Asia, South America, Africa are leading market share, more sufficient cash flow and profitability of the company are stronger.
|
| |
Previous article：The company received 3.3 billion yuan in financing, valued at 33.3 billion yuan
Next article：The price of two tickets for drug purchase will be cut by Qingdao and other pioneers
|
| |
|
|
